SI1638609T1 - Postopek za pripravo molekulskih kompleksov - Google Patents
Postopek za pripravo molekulskih kompleksovInfo
- Publication number
- SI1638609T1 SI1638609T1 SI200431896T SI200431896T SI1638609T1 SI 1638609 T1 SI1638609 T1 SI 1638609T1 SI 200431896 T SI200431896 T SI 200431896T SI 200431896 T SI200431896 T SI 200431896T SI 1638609 T1 SI1638609 T1 SI 1638609T1
- Authority
- SI
- Slovenia
- Prior art keywords
- molecular complexes
- preparation
- molecular
- recovered
- consist
- Prior art date
Links
Classifications
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
- A61K47/6949—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
- A61K47/6951—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes using cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR0305140A FR2854079B1 (fr) | 2003-04-25 | 2003-04-25 | Procede de preparation de complexes moleculaires |
| PCT/FR2004/000995 WO2004096284A1 (fr) | 2003-04-25 | 2004-04-23 | Procede de preparation de complexes moleculaires |
| EP04742568A EP1638609B1 (fr) | 2003-04-25 | 2004-04-23 | Procede de preparation de complexes moleculaires |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SI1638609T1 true SI1638609T1 (sl) | 2012-09-28 |
Family
ID=33104420
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SI200431896T SI1638609T1 (sl) | 2003-04-25 | 2004-04-23 | Postopek za pripravo molekulskih kompleksov |
Country Status (23)
| Country | Link |
|---|---|
| US (1) | US8741346B2 (sl) |
| EP (2) | EP2289561A1 (sl) |
| JP (1) | JP5037936B2 (sl) |
| KR (1) | KR101208256B1 (sl) |
| CN (1) | CN100594941C (sl) |
| AT (1) | ATE555811T1 (sl) |
| AU (1) | AU2004233621B2 (sl) |
| BR (1) | BRPI0409741B1 (sl) |
| CA (1) | CA2523342C (sl) |
| DK (1) | DK1638609T3 (sl) |
| ES (1) | ES2386437T3 (sl) |
| FR (1) | FR2854079B1 (sl) |
| HK (1) | HK1082430A1 (sl) |
| IL (1) | IL171520A (sl) |
| MX (1) | MXPA05011505A (sl) |
| NO (1) | NO335160B1 (sl) |
| NZ (1) | NZ543209A (sl) |
| PL (1) | PL1638609T3 (sl) |
| PT (1) | PT1638609E (sl) |
| RU (2) | RU2353392C2 (sl) |
| SI (1) | SI1638609T1 (sl) |
| WO (1) | WO2004096284A1 (sl) |
| ZA (1) | ZA200508469B (sl) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2876911B1 (fr) * | 2004-10-21 | 2007-04-13 | Pierre Fabre Medicament Sa | Complexe comprenant du piroxicam, une cyclodextrine et de l'arginine |
| EP1729813B1 (fr) | 2004-04-01 | 2011-04-06 | Pierre Fabre Medicament | Complexes d'inclusions comprenant du piroxicam, une cyclodextrine et l'arginine |
| FR2876914A1 (fr) * | 2004-10-21 | 2006-04-28 | Pierre Fabre Medicament Sa | Complexe comprenant un antibiotique, une cyclodextrine et un agent d'interaction |
| FR2876910B1 (fr) | 2004-10-21 | 2007-04-13 | Pierre Fabre Medicament Sa | Complexe comprenant la mequitazine, une cyclodextrine et un agent d'interaction |
| FR2944278B1 (fr) * | 2009-04-09 | 2011-11-18 | Pf Medicament | Procede de preparation de complexes moleculaires entre un agent retinoide et des cyclodextrines |
| FR2944207B1 (fr) | 2009-04-09 | 2011-05-06 | Galderma Res & Dev | Compositions comprenant au moins un complexe compose d'un derive d'acide naphtoique et d'au moins une cyclodestrine et leurs utilisations |
| FR2944280B1 (fr) | 2009-04-09 | 2012-08-03 | Galderma Res & Dev | Procede de preparation de complexes moleculaires entre adapalene et des cyclodextrines |
| JP5622187B2 (ja) * | 2009-09-08 | 2014-11-12 | 群泰生物科技股▲ふん▼有限公司 | 水溶性ミノキシジル組成物 |
| US10328152B2 (en) | 2011-06-16 | 2019-06-25 | Nayan Patel | Method for stabilization and delivery of therapeutic molecules |
| GB201609222D0 (en) | 2016-05-25 | 2016-07-06 | F2G Ltd | Pharmaceutical formulation |
| US10532102B2 (en) | 2016-08-19 | 2020-01-14 | Foresee Pharmaceuticals Co., Ltd. | Pharmaceutical composition and methods of uses |
| US11819503B2 (en) | 2019-04-23 | 2023-11-21 | F2G Ltd | Method of treating coccidioides infection |
| IL292404A (en) * | 2019-10-21 | 2022-06-01 | Esolate Ltd | Compositions including thin compounds and their production |
Family Cites Families (29)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB2191715B (en) | 1986-06-17 | 1990-07-25 | Midrex Int Bv | Method and apparatus for dedusting and desulfurizing gases |
| JPH0677511B2 (ja) | 1986-12-05 | 1994-10-05 | 金印わさび株式会社 | 香辛成分の包接化合物の製造方法 |
| US4822497A (en) | 1987-09-22 | 1989-04-18 | Modar, Inc. | Method for solids separation in a wet oxidation type process |
| DE3744329A1 (de) | 1987-12-28 | 1989-07-06 | Schwarz Pharma Gmbh | Verfahren zur herstellung einer mindestens einen wirkstoff und einen traeger umfassenden zubereitung |
| FR2629735B1 (fr) | 1988-04-11 | 1991-03-22 | Agronomique Inst Nat Rech | Procede d'extraction au dioxyde de carbone supercritique de composes volatils, et composes obtenus |
| GB9100643D0 (en) | 1991-01-11 | 1991-02-27 | Shaffery Michael J | Filter system |
| JP3043085B2 (ja) | 1991-03-18 | 2000-05-22 | 日本たばこ産業株式会社 | 包接化合物の製造方法 |
| US5389263A (en) | 1992-05-20 | 1995-02-14 | Phasex Corporation | Gas anti-solvent recrystallization and application for the separation and subsequent processing of RDX and HMX |
| DE59406065D1 (de) | 1993-03-24 | 1998-07-02 | Ciba Geigy Ag | Verfahren zur Herstellung einer Liposomendispersion im Hochdruckbereich |
| GB9313642D0 (en) | 1993-07-01 | 1993-08-18 | Glaxo Group Ltd | Method and apparatus for the formation of particles |
| EP0706821A1 (en) | 1994-10-06 | 1996-04-17 | Centre De Microencapsulation | Method of coating particles |
| FR2725990B1 (fr) | 1994-10-21 | 1997-01-10 | Pf Medicament | Derives hydrosolubles d'epipodophyllotoxine, leur procede de preparation, leur utilisation a titre de medicament, et leur utilisation destinee aux traitements anticancereux |
| FR2741619B1 (fr) | 1995-11-28 | 1998-02-13 | Pf Medicament | Nouveaux derives de 2,3,5-trimethyl-4-hydroxy-anilides, leur preparation et leur application en therapeutique |
| EP0885038B1 (en) | 1996-03-01 | 2011-06-15 | The University Of Kansas | Methods and apparatus for particle precipitation and coating using near-critical and supercritical antisolvents |
| FR2753639B1 (fr) | 1996-09-25 | 1998-12-11 | Procede de preparation de microcapsules de matieres actives enrobees par un polymere et nouvelles microcapsules notamment obtenues selon le procede | |
| US5766637A (en) | 1996-10-08 | 1998-06-16 | University Of Delaware | Microencapsulation process using supercritical fluids |
| DE19711393C1 (de) | 1997-03-19 | 1998-08-13 | Fraunhofer Ges Forschung | Verfahren zum Mikroverkapseln von Partikeln |
| GB9800936D0 (en) | 1997-05-10 | 1998-03-11 | Univ Nottingham | Biofunctional polymers |
| IT1296464B1 (it) | 1997-11-19 | 1999-06-25 | Vectorpharma Int | Composizioni farmaceutiche in forma di polveri di polimeri reticolati caricati con farmaci e relativo processo di preparazione mediante |
| GB9810559D0 (en) | 1998-05-15 | 1998-07-15 | Bradford Particle Design Ltd | Method and apparatus for particle formation |
| GB9824298D0 (en) | 1998-11-05 | 1998-12-30 | Smithkline Beecham Plc | Novel process |
| FR2798863B1 (fr) | 1999-09-27 | 2001-12-28 | Separex Sa | Procede et installation de mise a l'etat adsorbe sur un support poreux de composes actifs contenus dans un produit |
| FR2799984B1 (fr) | 1999-10-21 | 2002-05-03 | Lavipharm | Procede de fractionnement d'une matiere composee de plusieurs constituants a l'aide d'un solvant a pression supercritique |
| FR2803538B1 (fr) | 1999-12-15 | 2002-06-07 | Separex Sa | Procede et dispositif de captage de fines particules par percolation dans un lit de granules |
| FR2815540B1 (fr) * | 2000-10-19 | 2005-06-10 | Separex Sa | Procede de fabrication de tres fines particules constituees d'un principe insere dans une molecule hote |
| WO2002089851A1 (fr) | 2001-03-06 | 2002-11-14 | Separex (Societe Anonyme) | Procede de fabrication de complexes hote-client |
| FR2823207B1 (fr) * | 2001-04-10 | 2004-12-03 | Pf Medicament | Complexes d'anilides a chaine polycarbonee et de cyclodestrines, leur preparation et leur application en tant que medicamment en particulier pour le traitement des dislipidemies |
| FR2830760B1 (fr) * | 2001-10-12 | 2004-06-04 | Pf Medicament | Procede de preparation d'un compose d'interaction de substances actives avec un support poreux par fluide supercritique |
| FR2830761B1 (fr) * | 2001-10-12 | 2003-12-12 | Pf Medicament | Procede de preparation d'un compose d'interaction d'un derive anilide avec un support poreux par fluide supercritique |
-
2003
- 2003-04-25 FR FR0305140A patent/FR2854079B1/fr not_active Expired - Fee Related
-
2004
- 2004-04-23 BR BRPI0409741A patent/BRPI0409741B1/pt not_active IP Right Cessation
- 2004-04-23 MX MXPA05011505A patent/MXPA05011505A/es active IP Right Grant
- 2004-04-23 PT PT04742568T patent/PT1638609E/pt unknown
- 2004-04-23 CN CN200480014408A patent/CN100594941C/zh not_active Expired - Fee Related
- 2004-04-23 US US10/554,058 patent/US8741346B2/en not_active Expired - Fee Related
- 2004-04-23 DK DK04742568.1T patent/DK1638609T3/da active
- 2004-04-23 SI SI200431896T patent/SI1638609T1/sl unknown
- 2004-04-23 CA CA2523342A patent/CA2523342C/fr not_active Expired - Fee Related
- 2004-04-23 PL PL04742568T patent/PL1638609T3/pl unknown
- 2004-04-23 EP EP10179575A patent/EP2289561A1/fr not_active Withdrawn
- 2004-04-23 RU RU2005136664/15A patent/RU2353392C2/ru not_active IP Right Cessation
- 2004-04-23 WO PCT/FR2004/000995 patent/WO2004096284A1/fr active Search and Examination
- 2004-04-23 AT AT04742568T patent/ATE555811T1/de active
- 2004-04-23 EP EP04742568A patent/EP1638609B1/fr not_active Expired - Lifetime
- 2004-04-23 ES ES04742568T patent/ES2386437T3/es not_active Expired - Lifetime
- 2004-04-23 AU AU2004233621A patent/AU2004233621B2/en not_active Ceased
- 2004-04-23 NZ NZ543209A patent/NZ543209A/en not_active IP Right Cessation
- 2004-04-23 JP JP2006505810A patent/JP5037936B2/ja not_active Expired - Fee Related
-
2005
- 2005-10-19 ZA ZA200508469A patent/ZA200508469B/en unknown
- 2005-10-20 IL IL171520A patent/IL171520A/en active IP Right Grant
- 2005-10-25 KR KR1020057020310A patent/KR101208256B1/ko active IP Right Grant
- 2005-11-18 NO NO20055467A patent/NO335160B1/no not_active IP Right Cessation
-
2006
- 2006-04-06 HK HK06104203.9A patent/HK1082430A1/xx not_active IP Right Cessation
-
2008
- 2008-09-15 RU RU2008137041/15A patent/RU2008137041A/ru not_active Application Discontinuation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1082430A1 (en) | Method for the preparation of molecular complexes | |
| MY163029A (en) | Apparatus for making bio-organic compounds | |
| ATE546130T1 (de) | Dispersion von polymerteilchen | |
| DK1590006T3 (da) | Ultralydskontrastmidler og fremgangsmåde til frembringelse deraf | |
| NO20051305L (no) | Fremgangsmate for a behandle en formasjon | |
| NO20055641L (no) | Fremgangsmate for a behandle en underjordisk formasjon og vannbasert behandlingsvaeske til bruk ved utforelsen av fremgangsmaten | |
| AU2002212412A1 (en) | Method for making very fine particles consisting of a principle inserted in a host molecule | |
| NO20075525L (no) | Fremgangsmate og vaeske for syrebehandling av underjordiske formasjoner | |
| WO2005097201A3 (fr) | Complexes d’inclusions comprenant du piroxicam, une cyclodextrine et l’arginine | |
| MXPA02009275A (es) | Metodo para preparar dispersiones de alta presion/alto esfuerzo cortante que contienen ingredientes fisiologicamente activos. | |
| DE69920945D1 (de) | Verfahren zur herstellung von arzneistoffpartikeln | |
| WO2005098449A3 (en) | Hausp-mdm2 interaction and uses thereof | |
| AU2001257305A1 (en) | Hematology blood control and method for preparation of same | |
| AR070347A1 (es) | Uso de modificadores de permeabilidad relativa en el tratamiento de formaciones subterraneas | |
| AR032016A1 (es) | Una composicion catalizadora y los metodos para su preparacion y el uso en un proceso de polimerizacion | |
| ATE348630T1 (de) | Verminderung der nebenwirkungen der chemotherapie in krebspatienten | |
| BR0213220A (pt) | Processo de preparação de compostos de interação de uma substância ativa pouco solúvel em um meio aquoso com um suporte poroso, e, composto de interação de interação de uma substância ativa pouco solúvel em um meio aquoso em um suporte aquoso | |
| TW200632141A (en) | Method and system for injecting chemistry into a supercritical fluid | |
| AU2003292580A1 (en) | Latex polymer particles containing fluorescent substance or contrast medium and process for producing the same | |
| WO2002007752A3 (en) | Red blood cell as vehicle for agent-membrane translocation sequence conjugate | |
| RU2345114C1 (ru) | Жидкость для глушения скважин | |
| WO2003030867A3 (fr) | Procede de preparation d'un compose d'interaction d'un derive anilide avec un support poreux par fluide supercritique | |
| DE502004002309D1 (de) | Verfahren zur herstellung eines hydroxylierungskatalysators und seine verwendung | |
| EP1724576A3 (en) | Chromatography system with fluid intake management | |
| AU7269100A (en) | Method for indirectly determining the blood-clotting status |